封面
市场调查报告书
商品编码
1722845

2025 年至 2033 年连续血糖监测系统市场规模、份额、趋势及预测(按组件、人口统计、最终用户和地区划分)

Continuous Glucose Monitoring Systems Market Size, Share, Trends and Forecast by Component, Demographics, End User, and Region, 2025-2033

出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球连续血糖监测系统市场规模价值 70.4 亿美元。展望未来, IMARC Group估计到 2033 年市场规模将达到 109.2 亿美元,2025 年至 2033 年的复合年增长率为 4.75%。北美目前占据市场主导地位,2024 年的市占率将超过 38.7%。 CGM 设备的认知度和采用率不断提高、糖尿病盛行率不断上升、CGM 设备的重大技术进步以及向预防性医疗保健的持续转变是推动连续血糖监测系统市场份额增长的一些因素。

连续血糖监测系统 (CGMS) 是一种技术先进的设备,可自动追踪血糖水平。它们由发射器整合感测器组成,该感测器透过经皮或皮下途径连续测量组织液中的葡萄糖浓度。然后,发射器将讯息发送到可以夹在衣服上的无线监视器。持续血糖监测系统有助于提供糖尿病的完整概况,提醒血糖水平的高低,检测模式,并增加患者对身体活动、药物选择、食物份量和压力的洞察力。与传统的血糖监测设备相比,CGMS 无需刺痛,可以直接放置在皮肤上,有助于快速无痛地提供即时资讯。

持续血糖监测系统市场趋势:

全球范围内老年人口的不断增加使得患糖尿病的可能性增大,这为市场带来了积极的前景。 CGMS 通常用于测量体内的葡萄糖和胰岛素水平,如果其下降或上升到危险水平,则会进一步发出警报。与此一致,广泛使用产品来即时识别低血糖和高血糖情况有利于市场成长。此外,有助于检测糖尿病患者的糖化血红蛋白 (Hb1ac) 的 CGMS 的重大改进和新技术进步为市场成长提供了相当大的推动力。此外,人工胰臟装置系统与 CGMS 技术的结合可以泵送胰岛素并给予最佳剂量以管理患者的血糖水平,从而对市场成长产生积极影响。除此之外,非侵入性 CGMS 设备作为一种便捷的替代方案的引入、广泛的研究和开发 (R&D) 活动以及对少创或微创诊断工具的不断增长的需求预计将推动市场进一步增长。

本报告回答的关键问题

  • 持续血糖监测系统市场有多大?持续血糖监测系统市场的未来前景如何?
  • 推动持续血糖监测系统市场发展的关键因素有哪些?
  • 哪个地区占据连续血糖监测系统最大的市占率?
  • 全球连续血糖监测系统市场领先的公司有哪些?

目录

第一章:前言

第二章:范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章:执行摘要

第四章:简介

  • 概述
  • 主要行业趋势

第五章:全球连续血糖监测系统市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章:市场细分:按组成部分

  • 感应器
  • 发射器和接收器
  • 集成胰岛素泵

第七章:市场区隔:依人口统计

  • 儿童人口(<=14岁)
  • 成年人口(14岁以上)

第八章:市场区隔:按最终用户

  • 诊所和诊断中心
  • 重症监护室
  • 家庭医疗保健

第九章:市场细分:依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔:依国家

第十章:SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章:价值链分析

第 12 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章:价格分析

第 14 章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • A. Menarini Diagnostics Srl
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • Glysens Incorporated
    • LifeScan Inc. (Johnson & Johnson)
    • Medtronic PLC
    • Medtrum Technologies Inc.
    • Nemaura Medical Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings Inc.
    • Waveform Technologies Inc.
Product Code: SR112025A5377

The global continuous glucose monitoring systems market size was valued at USD 7.04 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 10.92 Billion by 2033, exhibiting a CAGR of 4.75% from 2025-2033. North America currently dominates the market, holding a market share of over 38.7% in 2024. The increasing awareness and adoption of CGM devices, rising prevalence of diabetes, significant technological advancements in CGM devices, and ongoing shift towards preventive healthcare are some of the factors boosting the continuous glucose monitoring systems market share.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

Breakup by Component:

  • Sensors
  • Transmitters and Receivers
  • Integrated Insulin Pumps

Breakup by Demographics:

  • Child Population (<=14 years)
  • Adult Population (>14 years)

Breakup by End User:

  • Clinics and Diagnostics Centers
  • ICUs
  • Home Healthcare

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report

  • 1.How big is the continuous glucose monitoring systems market?
  • 2.What is the future outlook of continuous glucose monitoring systems market?
  • 3.What are the key factors driving the continuous glucose monitoring systems market?
  • 4.Which region accounts for the largest continuous glucose monitoring systems market share?
  • 5.Which are the leading companies in the global continuous glucose monitoring systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Continuous Glucose Monitoring Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Sensors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transmitters and Receivers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Integrated Insulin Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Demographics

  • 7.1 Child Population (<=14 years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Adult Population (>14 years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Clinics and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 ICUs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Healthcare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 A. Menarini Diagnostics S.r.l.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DexCom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Glysens Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 LifeScan Inc. (Johnson & Johnson)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Medtronic PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtrum Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Nemaura Medical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Senseonics Holdings Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Waveform Technologies Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2024
  • Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2024
  • Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
  • Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
  • Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million USD), 2025-2033
  • Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million USD), 2025-2033
  • Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
  • Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players